Overview and Scope
Lyophilization services for biopharmaceuticals refer to freeze-drying biopharmaceutical products to enhance their stability, extend their shelf life, and facilitate storage and transportation. This method preserves and stabilizes biopharmaceuticals by removing water from the product in a frozen state.
Sizing and Forecast
The lyophilization services for biopharmaceuticals market size has grown rapidly in recent years. It will grow from $1.66 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to biopharmaceutical expansion, drug patent expirations, rise in personalized medicine, increase in clinical trials, globalization of biopharmaceutical market..
The lyophilization services for biopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $2.74 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to emergence of mrna and nucleic acid therapeutics, outsourcing trends in pharma industry, focus on continuous manufacturing, advancements in combination therapies, growth of biosimilars production.. Major trends in the forecast period include quality-by-design (qbd) implementation, automation and robotics integration, focus on sustainability, customization for complex molecules, shift towards continuous lyophilization..
To access more details regarding this report, visit the link:
Segmentation & Regional Insights
The lyophilization services for biopharmaceuticals market covered in this report is segmented –
1) By Type: Product And Cycle Development, Clinical Manufacturing, Commercial Manufacturing, Freeze Drying Analytical Services
2) By Type Of Primary Packaging System: Vials, Syringes, Cartridges, Ampoules, Other Primary Packaging Systems
3) By Application: Pharmaceutical And Biotechnology Companies, Research Institutes, Other Applications
North America was the largest region in the lyophilization services for biopharmaceuticals market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyophilization services for biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12064&type=smp
Major Driver Impacting Market Growth
The growing demand for biologics is expected to propel the growth of the lyophilization services for the biopharmaceuticals market going forward. Biologics are therapeutic products derived from living organisms or containing components of living organisms. Lyophilization services are commonly used for biologics in the pharmaceutical and biopharmaceutical industries. This process helps preserve the stability of biologics by preventing them from denaturing or degrading. It is also beneficial for stability enhancement and improving product integrity. For instance, in November 2022, according to the reports shared by the Canadian Institute for Health Information., a Canada-based government health company, biologics accounted for 2.3% of claims and $4.4 billion (29.4%) of the total spending on public medication programs in 2021. Furthermore, according to the US Food and Drug Administration, a US-based federal agency of the Department of Health and Human Services, by the end of 2022, 40 biosimilars had received approval, and 27 of them were available in the United States, where they were pitted against 10 brand-name biologics. Therefore, the growing demand for biologics drives the lyophilization services for the biopharmaceuticals market.
Key Industry Players
Major companies operating in the lyophilization services for biopharmaceuticals market report are Strides Pharma Science Limited, Baxter International Inc., Catalent Pharma Solutions Inc, W. L. Gore & Associates Inc, Emergent BioSolutions Inc., Vetter Pharma International GmbH, Curia Global Inc., Corden Pharma GmbH, CinnaGen Co., Lyophilization Services of New England Inc., Jubilant HollisterStier LLC, Dalton Pharma Services, IDT Biologika GmbH, Ardena Group, Axcellerate Pharma LLC, Symbiosis Pharmaceutical Services, Lyka Labs Limited, Biofortuna Limited, Rentschler Fill Solutions GmbH, Lyophilization Technology Inc., Pyramid Laboratories Inc, ATTWILL Medical Solutions, AB BioTechnologies Inc., Biopharma Process Systems, Labyrinth Biopharma LLC, Gilyos GmbH, ProJect Pharmaceutics GmbH, BioZed Engineering Pvt. Ltd., Berkshire Sterile Manufacturing, Millrock Technology Inc.
The lyophilization services for biopharmaceuticals market report table of contents includes:
1. Executive Summary
2. Lyophilization Services For Biopharmaceuticals Market Characteristics
3. Lyophilization Services For Biopharmaceuticals Market Trends And Strategies
4. Lyophilization Services For Biopharmaceuticals Market - Macro Economic Scenario
5. Global Lyophilization Services For Biopharmaceuticals Market Size and Growth
.
.
.
32. Global Lyophilization Services For Biopharmaceuticals Market Competitive Benchmarking
33. Global Lyophilization Services For Biopharmaceuticals Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Lyophilization Services For Biopharmaceuticals Market
35. Lyophilization Services For Biopharmaceuticals Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
